ArticleScientific reports2014

Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.

Yun-Qing Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.